About 25,200,000 results
Open links in new tab
Vigil Neuroscience Reports Positive Data from its Phase 1 Clinical ...
Vigil Neuroscience Reports Positive Data from its Phase 1 Clinical ...
Optimistic Outlook for Vigil Neuroscience Inc: Promising Phase 1 ...
Vigil Neuroscience Highlights 2024 Corporate Achievements and …
Vigil Neuroscience's Alzheimer's Candidate Shows Encouraging …
Vigil Neuroscience Reports Positive Phase 1 Data Supporting …
Vigil’s TREM2-Targeted Alzheimer’s Treatment Shows Early
Vigil Neuroscience, Inc. (VIGL) Stock Price, News, Quote & History ...
News — Vigil Neuroscience, Inc
Vigil Neuroscience Reports Third Quarter 2024 Financial Results …
- Some results have been removed